globenewswire news
2026-10-16T21:34:37Z
BRISBANE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly...
2026-10-16T21:30:00Z
TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived...
2026-10-16T21:15:00Z
PHILADELPHIA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte...
2026-10-16T21:05:00Z
Unsecured, non-interest-bearing loan provides additional working capital support
2026-10-16T20:26:07Z
SOUTHLAKE, Texas, Oct. 16, 2026 (GLOBE NEWSWIRE) -- HealthRecon Connect, a technology-enabled Revenue Cycle Management solutions provider to U.S. healthcare organizations, today announced the successful completion of its ISO surveillance...
2026-10-16T20:15:00Z
WALTHAM, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development...
2026-10-16T20:05:00Z
CAMBRIDGE, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA®) platform to develop...
2026-10-16T20:05:00Z
PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today provided a brief business update...
2026-10-16T20:05:00Z
EMERYVILLE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to...
2026-10-16T20:01:00Z
WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Chardan Healthcare...
2026-10-16T18:22:39Z
Advanced credential strengthens access to expert skin care for patients across Pittsburg, Southeast Kansas, and Southwest Missouri
2026-10-16T16:00:00Z
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 October 2026 – 6 PM CET
2026-10-16T16:00:00Z
K2 Vision has surpassed over 5,000 Light Adjustable Lens Procedures
2026-10-16T16:00:00Z
FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults in the United States
2026-10-16T15:00:00Z
Backed by eight retail locations and over 125,000 deliveries completed, Whole Lotta Dank launches its first cannabis brand, advances 20+ SKUs and seeks long-term partnerships with Canadian producers
2026-10-16T14:34:33Z
BANGALORE, India, Oct. 16, 2026 (GLOBE NEWSWIRE) -- As interest grows in memory, focus and mental sharpness throughout life, new clinical research is exploring the potential of a centuries-old botanical...
2026-10-16T13:35:09Z
SAN DIEGO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kexing Biopharm (688136.SH) recently announced that it has received a Notice of Acceptance from China’s National Medical Products Administration (NMPA) for the biologics...
2026-10-16T13:20:00Z
HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of...
2026-10-16T13:15:00Z
Prairie Cannabis Launches Breast Cancer Awareness Fundraiser Supporting Gilda's Club Chicago Throughout October
2026-10-16T13:15:00Z
BMRT’s Base Molecular Resonance™ Technology Detects the Molecular Signature of a Concealed Firearm from More Than 500 Feet Away and Identifies Drugs Inside Vehicles and Backpacks at a Distance; Expansion...
2026-10-16T12:56:04Z
Why Abu Dhabi Strategy and New Banking Director Signal Bigger Global Ambition
2026-10-16T12:46:35Z
CHARLOTTE, N.C., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Hemp Hop, a premium THCa Dispensary brand founded in Charlotte, North Carolina, in 2018, has announced the launch of its new Mini Pre...
2026-10-16T12:39:45Z
PRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of...
2026-10-16T12:36:37Z
New Preclinical Findings Identify Potential Strategy to Remodel Resistant Tumor State & Restore Therapeutic Vulnerability
2026-10-16T12:30:00Z
DOYLESTOWN, Pa., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of...
2026-10-16T12:29:49Z
Final European Commission decision expected during Q4 2026
2026-10-16T12:19:00Z
IRVINE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) ("Biomerica" or the "Company") today reported financial results for the first quarter of fiscal 2027, ended August 31,...
2026-10-16T12:00:00Z
BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it...
2026-10-16T12:00:00Z
Recognition honors hear.com’s Clinic-in-a-Box® teleaudiology platform and Horizon IX hearing aids for expanding access to personalized, medical-grade hearing care
2026-10-16T12:00:00Z
Agreement aims to expand the commercial reach of Nanox.AI's Bone Solution in the Italian healthcare market.
2026-10-16T12:00:00Z
Clearance expands twiist's precise insulin delivery and personalized automation to the largest population of people treated with insulin, with time-in-range improvements seen in as little as one day in a...
2026-10-16T11:30:00Z
PALO ALTO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced...
2026-10-16T11:00:00Z
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director
2026-10-16T11:00:00Z
Company to host PDAC focused investor webcast on Friday, October 23, 2026, 7:30 am ET
2026-10-16T11:00:00Z
Positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after first 12 weeks of treatment
2026-10-16T11:00:00Z
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham
2026-10-16T11:00:00Z
Former Dermavant Chief Scientific Officer led development of tapinarof, the first FDA-approved AhR agonist, from mechanistic understanding through approval and commercialization
2026-10-16T11:00:00Z
BOSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab,...
2026-10-16T10:42:01Z
Sheridan, Wyoming, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides has added Semax [https://kylopeptides.com/product/semax/] to its research catalog this week. The compound is a synthetic peptide supplied only for laboratory...
2026-10-16T10:31:28Z
BEERSE, BELGIUM, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson, a worldwide leader in multiple myeloma, today announced that the Committee for Medicinal Products for Human Use (CHMP) of...
2026-10-16T07:09:26Z
STOCKHOLM, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Senturi Pharma AB and Digestive Care, Inc. today announced the signing of an exclusive distribution agreement concerning PERTZYE® (pancrelipase) in Europe.
2026-10-16T06:26:12Z
BEIJING, Oct. 16, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three...
2026-10-16T06:00:00Z
Louvain-la-Neuve, Belgium, and Paris, France, 16 October 2026, 8:00 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and radiopharmaceutical production solutions, and Framatome,...
2026-10-16T05:00:00Z
Basel, 16 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab) for the treatment of adults...
2026-10-16T04:47:10Z
Extending the Company's Immunologically Cold Tumor Strategy into Colorectal Cancer
2026-10-16T02:37:02Z
CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY) (“City” or “City Therapeutics”), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics,...
2026-10-15T20:34:00Z
The cover story explores how the German health sociologist applies evidence-based 80/20 principles to help self-employed professionals and entrepreneurs build sustainable personal health systems.
2026-10-15T20:30:00Z
Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of...
2026-10-15T20:29:52Z
BRISBANE, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests, today announced that the Company plans to release its...
2026-10-15T20:15:00Z
More than 125 patients dosed in ASCEND across the United States, Europe and South Korea; dose escalation complete